Genetic influence of plasma homocysteine on Alzheimer's disease
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 01, 2018
- Source ID
- 10.1016/j.neurobiolaging.2017.09.033
Entities
People
- Arash Nazeri
- Aristotle N. Voineskos
- Daniel Felsky
- David A. Bennett
- Julie A. Schneider
- Philip L. De Jager
- Tina Roostaei
Organizations
- AbbVie
- Alzheimer Society of Canada
- Alzheimer's Association
- Alzheimer's Disease Neuroimaging Initiative
- Alzheimer's Drug Discovery Foundation
- Alzheimer's Research UK
- BioClinica
- Biogen
- Brain & Behavior Research Foundation
- Bristol-Myers Squibb
- Canadian Institutes of Health Research
- Centre for Addiction and Mental Health
- Chiron Corporation
- Eisai
- Eli Lilly and Company
- Erasmus MC
- Erasmus University Rotterdam
- Federal Ministry of Research, Technology and Space
- French National Institute of Health and Medical Research
- GE HealthCare
- Hoffmann-La Roche
- Icelandic Heart Association
- Innogenetics
- Johnson & Johnson
- Labex (Sweden)
- Laboratoires Servier
- Lundbeck
- Medical Research Council
- Merck & Co.
- Meso Scale Diagnostics (United States)
- National Heart, Lung, and Blood Institute
- National Institute of Biomedical Imaging and Bioengineering
- National Institute of Mental Health
- National Institute on Aging
- National Institutes of Health
- Ontario Mental Health Foundation
- Pasteur Institute
- Pfizer
- Roche (United States)
- Takeda Pharmaceutical Company
- United States Department of Defense
- University Lille-II
- University of Lille Nord de France
- Wellcome